The nurse is reviewing her hospitalized client's medications and sees that he is on both a cephalosporin and an aminoglycoside. The nurse knows that this combination of antibiotics increases the client's risk for:

A. IgE (Immunoglobulin E): This class of antibodies is primarily involved in hypersensitivity reactions Type I, which are immediate allergic reactions. When a person is exposed to an allergen they are sensitive to, IgE antibodies on the surface of mast cells and basophils bind to the allergen. This triggers the release of inflammatory mediators like histamine, leading to allergic symptoms such as itching, hives, and in severe cases, anaphylaxis.

B. IgA (Immunoglobulin A): IgA antibodies are primarily found in mucosal areas such as the respiratory and gastrointestinal tracts. They play a role in immune defense on mucosal surfaces and are important for preventing infections. While IgA is not directly associated with hypersensitivity reactions Type I, deficiencies in IgA can sometimes lead to increased susceptibility to certain infections.

C. IgG (Immunoglobulin G): IgG antibodies are the most common type of antibody in the bloodstream and are involved in various immune responses, including defense against bacterial and viral infections. IgG antibodies are not specific to Type I hypersensitivity reactions; they are part of the immune system's broader defense mechanisms.

D. IgM (Immunoglobulin M): IgM antibodies are the first antibodies to be produced in response to an infection. They are large pentameric molecules and are effective at agglutinating pathogens. IgM antibodies are involved in the primary immune response to infections, but they are not specifically associated with Type I hypersensitivity reactions.

A. "The antibiotic I have been taking doesn't work as well as it used to."
This statement shows awareness of decreased effectiveness, which can occur due to drug resistance. Bacteria can become resistant to antibiotics, leading to reduced efficacy of the medication over time.

B. "The bacteria in my body have become resilient."
This statement correctly attributes resistance to the bacteria. Resilience in this context means that bacteria have developed mechanisms to survive the effects of antibiotics, making the treatment less effective.

C. "Over time, an organism that had once been highly sensitive to an antibiotic may become less susceptible, or it may lose drug sensitivity entirely."
This statement accurately describes the concept of drug resistance. Bacteria can lose sensitivity to antibiotics, rendering the drugs ineffective against them.

D. "My body has become resistant to the antibiotic."
This statement is incorrect. It's the bacteria that develop resistance, not the patient's body. Patients don't become resistant to antibiotics; instead, bacteria evolve and adapt, making the drugs less effective against them.